Skip to content

Autonomic Challenges From Mild Hypovolemia and Mechanical Ventilation

Effects of Low Central Volume and Intermittent Positive Pressure Ventilation on the Heart Rate Variability

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03244891
Enrollment
12
Registered
2017-08-10
Start date
2019-06-15
Completion date
2019-07-30
Last updated
2019-10-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Autonomic Nervous System Imbalance, Hypovolemia, Positive-Pressure Respiration

Brief summary

Heart Rate Variability (HRV) analysis has been studied in the critically ill patients although it is affected by several uncontrolled variables in the clinical conditions. The aim of this trial is to measure the effects of mildly reduced central volume and cyclic variation of intrathoracic pressure on the variables frequently used to describe the HRV.

Detailed description

Twelve healthy volunteers will be studied. Mild hypovolemia will be induced by 12 hours fasting from food and drinks. At 8.30 AM the study protocol will start. The studied subjects will lie calm supine in a ICU bed able to provide passive head up and head down tilt. They will be connected to a Siemens SC9000 monitor showing their ECG waves and to a Nexfin (BMEYE) monitor for continuous noninvasive blood pressure (NBP) assessment. Both waves (ECG and NBP) will be recorded on a laptop PC through analogic/digital input/output converter (PowerLab 8/35, ADinstruments). The studied subjects will undergo to a sequence of (1) spontaneous breathing at 10 degrees head up, (2) spontaneous breathing at 7 degrees head down, (3) noninvasive ventilation at 10 degrees head up, and (4) noninvasive ventilation at 7 degrees head down. The sequence 1-2-3-4 will be randomized. After this four phases, a fluid challenge of ringer acetate 15ml\*kg will be intravenously administered and the a sequence 1-2-3-4 will be repeated after a new randomization. Noninvasive ventilation will be provided with a facial mask with ventilatory setting: Psupp 8 cmH2O, PEEP 5 cmH2O, FiO2 0.28. Psupp will be decreased by 2 cmH2O steps if the inspiratory tidal volume will be \>10ml\*kg. During both spontaneous breathing and noninvasive ventilation the subjects will breathe following a metronome at 18bpm. HRV analysis will be conducted following the recommendation of the Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology (see reference). Furthermore, the healthy volunteers will be studied by trans-thoracic ultrasound assessment with a Philips EPIQ7 sonographer, during each study phase.

Interventions

OTHERIncrease of central volume

Mild hypovolemia will be induced in healthy volunteers by 12 hours fasting. Three conditions will be considered for the analysis, each of them both during spontaneous breathing and positive pressure ventilation: 1. baseline 2. after fluid shift induced by passive head down position at 15 degrees 3. after fluid challenge with Ringer acetate 15ml\*kg in head down position A total of six steps will be considered for the analysis

OTHERVentilation mode

Each previous step will be done in two respiratory conditions: 1. spontaneous breathing 2. noninvasive ventilation via facial mask in pressure support mode at 8 cmH2O above positive end expiratory pressure of 5 cmH2O, inspiratory fraction of oxygen of 0.25 In both conditions respiratory rate will be set at 18 breaths per min following a metronome

Sponsors

ASST Fatebenefratelli Sacco
Lead SponsorOTHER

Study design

Intervention model
SEQUENTIAL
Primary purpose
BASIC_SCIENCE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 35 Years
Healthy volunteers
Yes

Inclusion criteria

* healthy volunteers

Exclusion criteria

* history of cardiac, metabolic, respiratory, renal, neurological or hematologic disease of any kind * chronically assuming drugs of any kind * non sinus cardiac rhythm * ectopic beats \>5% of all cardiac beats * claustrophobia or unable to tolerate noninvasive ventilation via facial mask

Design outcomes

Primary

MeasureTime frameDescription
Effects of increasing central blood volume on heart rate variability10 mins each stepThe studied subjects will undergo to increase of central blood volume in two steps: 1. passive head down tilt at -7 degrees 2. intravenous infusion of ringer acetate of 15ml\*kg body weight
Effect of cyclic intrathoracic pressure oscillations on heart rate variability10 min each stepThe studied subject will undergo to two ventilatory modes: 1. spontaneous breathing at 18 breaths per min 2. positive pressure ventilation via face mask

Secondary

MeasureTime frameDescription
Effects of increasing central blood volume and of cyclic intrathoracic pressure oscillations on echographic cardiac function variables10 mins each stepAt each step cardiac functionality assessment will be done by transthoracic echocardiography

Countries

Italy

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026